ScientiaAdvisor
-
@ from @ participating in Genome-wide Partnering & Dealmaking Conference in Boston this week
10:43 AM May 30th
via web
-
@ will deliver the keynote address on "The Road to Translation" at the Genomics Forum 2012 @
6:06 AM May 15th
via web
-
I uploaded a @ video Anderson_Q&A_selection.m4v
10:33 AM May 11th
via Google
-
Dr. Anderson @. He talked about research done at the Wellman Center and what motivates their research
10:20 AM May 11th
via web
-
Read @ blog: @ webcast recap on Biosimilars & FDA Guidelines: Opportunities & Implications
1:41 PM May 10th
via web
-
@ Jonathan Pan comments on GSK's offer to acquire Human Genome Sciences @
10:42 AM May 10th
via web
-
@ comments on Possible Cut Backs of Medco's Personalized Medicine Programs
7:12 AM May 9th
via web
-
Read the latest on our blog: @ delivered keynote speech at the opening of Sony's Cambridge office
9:49 AM May 7th
via web
-
@ delivers keynote at Sony DADC’s Boston groundbreaking ceremony
2:00 PM May 1st
via TweetDeck
-
Glorikian quoted on Sony's expansion into healthcare
10:00 AM May 1st
via LinkedIn
-
Jonathan Pan @ presented @ webinar: Biosimilars & FDA Guidelines:Opportunities & Implications
12:09 PM Apr 30th
via web
-
Read @ blog: Medical Devices Companies Targeting Non-Medical Applications: The Case of Neuromarketing
10:55 AM Apr 13th
via web
-
Read @ newest blog: Next Generation RegenerativeTherapies Leverage Biomaterial-Cell Combination
6:31 AM Apr 6th
via web
-
Luminary Insights from Dr Patrice Milos, Boston Site Head - Pfizer’s Centers for Therapeutic Innovation. View video at
10:54 AM Apr 3rd
via web
-
Unconventional deals to herculean strategies
10:43 AM Apr 3rd
via LinkedIn
-
Stay tuned for video excerpts from Dr. Milos' visit on @
7:15 AM Mar 30th
via TweetDeck
-
Industry is trying to innovate new and effective ways of performing research to enable personalized medicine.
7:00 AM Mar 30th
via TweetDeck
-
We will eventually learn more about drug/physiological pathways, and this opportunity will become more available for translational research.
6:58 AM Mar 30th
via TweetDeck
-
No central nervous system biologics projects are being pursued by CTI due to the higher complication of these drug/physiological pathways.
6:57 AM Mar 30th
via TweetDeck
-
CTI has been around for a year and has already screened 300 proposals. This may be the beginning of a new business model of biologics R&D.
6:55 AM Mar 30th
via TweetDeck
|
- Name ScientiaAdvisors
- Location Cambridge, MA
- Web http://www.scient...
- Bio The official Twitter account for Scientia Advisors, a leading growth strategy firm for companies operating across the healthcare industry value chain.
|